Kinetics of the Cell Cycle Arrest Biomarkers (TIMP2 and IGFBP7) for the Diagnosis of Acute Kidney Injury in Critically Ill COVID-19 Patients.
Massimiliano GrecoSilvia De RosaFabian BoehmSofia SpanoRomina AcetoAntonio VozaFrancesco ReggianiMarta CalatroniGianluca CastellaniElena CostantiniGianluca VillaMaurizio CecconiPublished in: Diagnostics (Basel, Switzerland) (2023)
Urinary biomarkers [TIMP-2]*[IGFBP-7] were generally increased in this population with a high prevalence of AKI, and were higher in patients with severe AKI measured at 12 h from ICU admission. Further studies are needed to evaluate the best timing of these biomarkers in this population.